Target RWE Acquires NoviSci, Gains Amgen Investment

January 20, 2021

Target RWE, a clinical data company based in Durham, didn’t have to go far to find a strategic partner to boost its analytical prowess. The company has acquired NoviSci, a software analysis and services company located in downtown Durham, seven miles away.

Categories: NoviSci

Biotech giant Amgen is doubling down on a Durham health data startup with ties to Duke

January 15, 2021

Amgen, one of the largest biotechnology companies in the world, is doubling down on its investment into a Durham health data startup called NoviSci. NoviSci, founded by two Duke University professors, builds statistical software that companies use to evaluate the effectiveness of drugs in patients.

Categories: NoviSci

Genentech Launches $1B+ RNA Collaboration with Ribometrix

January 6, 2021

Genentech, a member of the Roche Group, will apply Ribometrix’s discovery platform to discover, develop, and commercialize small molecule drug candidates against RNA targets, through a collaboration that could generate more than $1 billion for the Durham, NC-based developer of RNA-based small molecule therapeutics.

Categories: Ribometrix

410 Medical Awarded FDA 510k Clearance for LifeFlow PLUS

November 3, 2020

Durham startup 410 Medical has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for its LifeFlow PLUS Blood and Fluid Infuser (LifeFlow PLUS).

Categories: 410 Medical

National Academy of Engineering Recognizes Ligler With Leadership Award

October 5, 2020

Frances S. Ligler, Ross Lampe Distinguished Professor in the UNC/NC State Joint Department of Biomedical Engineering, has been recognized by the National Academy of Engineering (NAE) with its Simon Ramo Founders Award.

Categories: Advisory Board News